JP2024525239A5 - - Google Patents
Info
- Publication number
- JP2024525239A5 JP2024525239A5 JP2023563075A JP2023563075A JP2024525239A5 JP 2024525239 A5 JP2024525239 A5 JP 2024525239A5 JP 2023563075 A JP2023563075 A JP 2023563075A JP 2023563075 A JP2023563075 A JP 2023563075A JP 2024525239 A5 JP2024525239 A5 JP 2024525239A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- polyoxyethylene
- castor oil
- cerebral infarction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021070892 | 2021-04-20 | ||
| JP2021070892 | 2021-04-20 | ||
| PCT/US2022/025462 WO2022226013A1 (en) | 2021-04-20 | 2022-04-20 | Pharmaceutical composition comprising the compound smtp-7 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525239A JP2024525239A (ja) | 2024-07-11 |
| JP2024525239A5 true JP2024525239A5 (enExample) | 2025-04-30 |
Family
ID=81648879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563075A Pending JP2024525239A (ja) | 2021-04-20 | 2022-04-20 | 化合物ｓｍｔｐ－７を含有する医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240238252A1 (enExample) |
| EP (1) | EP4326258A1 (enExample) |
| JP (1) | JP2024525239A (enExample) |
| KR (1) | KR20230173129A (enExample) |
| CN (1) | CN117279634A (enExample) |
| AU (1) | AU2022262593A1 (enExample) |
| BR (1) | BR112023021803A2 (enExample) |
| CA (1) | CA3214630A1 (enExample) |
| WO (1) | WO2022226013A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026092761A1 (zh) * | 2024-11-04 | 2026-05-07 | 江苏恒瑞医药股份有限公司 | 包含smtp衍生物的药物组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4313049B2 (ja) | 2003-01-23 | 2009-08-12 | 株式会社ティーティーシー | 血管新生関連疾患の予防又は治療用医薬組成物 |
| JP2004224737A (ja) | 2003-01-23 | 2004-08-12 | Ttc:Kk | 新規トリプレニルフェノール化合物 |
| EP1944027A4 (en) | 2005-10-06 | 2009-08-19 | Univ Tokyo Nat Univ Corp | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF NEPHRITIS AND METHOD OF MANUFACTURE THEREOF |
| EP2604697B1 (en) | 2006-03-27 | 2015-07-01 | Tokyo University of Agriculture and Technology TLO | Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer |
| ES2476041T3 (es) * | 2009-07-06 | 2014-07-11 | National University Corporation Tokyo University Of Agriculture And Technology | Agente citoprotector trifenilfen�lico |
| WO2011125930A1 (ja) | 2010-04-02 | 2011-10-13 | 日本製薬株式会社 | 炎症性腸疾患又は自己免疫性の末梢神経障害の予防又は治療剤 |
| AU2022275263A1 (en) * | 2021-05-10 | 2023-11-09 | Corxel Pharmaceuticals Hong Kong Limited | Pharmaceutical composition for use in treating cerebral infarction |
-
2022
- 2022-04-20 AU AU2022262593A patent/AU2022262593A1/en active Pending
- 2022-04-20 WO PCT/US2022/025462 patent/WO2022226013A1/en not_active Ceased
- 2022-04-20 CA CA3214630A patent/CA3214630A1/en active Pending
- 2022-04-20 US US18/287,489 patent/US20240238252A1/en active Pending
- 2022-04-20 CN CN202280033984.6A patent/CN117279634A/zh active Pending
- 2022-04-20 BR BR112023021803A patent/BR112023021803A2/pt unknown
- 2022-04-20 JP JP2023563075A patent/JP2024525239A/ja active Pending
- 2022-04-20 EP EP22723282.4A patent/EP4326258A1/en active Pending
- 2022-04-20 KR KR1020237038571A patent/KR20230173129A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7130818B2 (ja) | 特異的炎症収束性メディエーターの塩に関連する組成物及び方法 | |
| HRP20241643T1 (hr) | Derivati masnih kiselina za liječenje nealkoholnog steatohepatitisa | |
| JP2012526094A5 (enExample) | ||
| JP2023518035A5 (enExample) | ||
| JP2022529720A (ja) | レナリドミドまたは他の免疫調節剤の持続投与 | |
| JP2024544415A5 (enExample) | ||
| JP2023522065A5 (enExample) | ||
| JP2018515463A5 (enExample) | ||
| JP2024523411A5 (enExample) | ||
| JP3802105B2 (ja) | ジクロフェナクナトリウム含有乳化外用剤 | |
| TW202228706A (zh) | 穩定之醫藥組合物 | |
| JP2022519317A5 (enExample) | ||
| JP2022510587A5 (enExample) | ||
| JP2022511730A5 (enExample) | ||
| US8168670B2 (en) | Pyrazolone derivative emulsion formulations | |
| JP2022538505A5 (enExample) | ||
| JP4866546B2 (ja) | ジクロフェナク含有乳剤性軟膏剤 | |
| KR20220161356A (ko) | 자발적 수용이 개선된 조성물 | |
| JP2006509038A5 (enExample) | ||
| RU2014141341A (ru) | Паралитический яд моллюсков | |
| JP4843824B2 (ja) | 外用剤 | |
| WO2020241605A1 (ja) | 外用剤 | |
| TW201630606A (zh) | 包含局部藥物之蓋崙（ｇａｌｅｎｉｃ）調配物 | |
| TWI387586B (zh) | 吡唑酮衍生物調配物 | |
| JP2024522783A5 (enExample) |